Neurofibrosarcoma - 25 Studies Found
Not yet recruiting |
: Study of CPI-0610 in Patients With Malignant Peripheral Nerve Sheath Tumors : Peripheral Nerve Tumors : 2016-11-21 : Drug: CPI-0610
|
Recruiting |
: Transformation of Plexiform Neurofibromas to Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 :
: 2014-08-06 :
|
Completed |
: Sorafenib and Dacarbazine in Soft Tissue Sarcoma :
|
Recruiting |
: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma :
|
Terminated |
: Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS) :
|
Recruiting |
: Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Hydrochloride Before Surgery in Treating Patients With Newly Diagnosed Non-Rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery :
|
Recruiting |
: Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma :
|
Active, not recruiting |
: Trial of Dasatinib in Advanced Sarcomas :
: 2007-04-20 : Drug: Dasatinib oral agent, continuous dosing, Cycles = 28 days |
Completed |
: Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent Sarcoma :
|